Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 95,086 shares at $167.99 ($16.2M) on 2024-03-11, disclosed to the SEC on 2024-03-11.
Scheduled sale ($16.2M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $167.99 | 2,146 | $361K | 2.2% |
| 2 | $167.99 | 2,146 | $361K | 2.2% |
| 3 | $168.15 | 2,658 | $447K | 2.8% |
| 4 | $168.15 | 2,658 | $447K | 2.8% |
| 5 | $168.88 | 2,254 | $381K | 2.3% |
| 6 | $168.88 | 2,254 |
| $381K |
| 2.3% |
| 7 | $168.96 | 1,646 | $278K | 1.7% |
| 8 | $168.96 | 1,646 | $278K | 1.7% |
| 9 | $170.32 | 5,109 | $870K | 5.4% |
| 10 | $170.32 | 5,109 | $870K | 5.4% |
| 11 | $170.42 | 8,040 | $1.4M | 8.4% |
| 12 | $170.42 | 8,040 | $1.4M | 8.4% |
| 13 | $170.93 | 8,002 | $1.4M | 8.4% |
| 14 | $170.93 | 8,002 | $1.4M | 8.4% |
| 15 | $171.09 | 5,469 | $936K | 5.8% |
| 16 | $171.09 | 5,469 | $936K | 5.8% |
| 17 | $172.06 | 2,816 | $485K | 3.0% |
| 18 | $172.06 | 2,816 | $485K | 3.0% |
| 19 | $172.21 | 2,800 | $482K | 3.0% |
| 20 | $173.09 | 3,359 | $581K | 3.6% |
| 21 | $173.09 | 3,359 | $581K | 3.6% |
| 22 | $173.30 | 3,587 | $622K | 3.8% |
| 23 | $173.30 | 3,587 | $622K | 3.8% |
| 24 | $174.00 | 1,314 | $229K | 1.4% |
| 25 | $174.13 | 800 | $139K | 0.9% |
| Total | $170.85 avg | 95,086 | $16.2M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |